Immunic, Inc. (IMUX)

Every figure this model derived for IMUX, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 329,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 155,098,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 157,833,000 AssetsCurrent 2026-06-30
current liabilities 31,260,000 LiabilitiesCurrent 2026-06-30
equity 127,581,000 StockholdersEquity 2026-06-30
interest expense 0 InterestPaidNet 2020-09-30
ocf -87,720,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
sbc 16,170,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up IMUX on one particular measure came for.

RatioValue
current ratio5.05
current ratio reported5.05
dilution pct55.46

What to be careful about

What this model itself distrusts about IMUX's figures. Written by the derivation as it ran, not added afterwards.